Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
REDWOOD CITY, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on...
REDWOOD CITY, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on...
Company sees significant momentum in Pharmaloz, Nebula Genomics and ProPhase BioPharma Pharmaloz Manufacturing plans on track to increase capacity from...
VOQUEZNA® (vonoprazan) tablets approved by the U.S. Food and Drug Administration (FDA) for the treatment of Erosive GERD and relief...
MISSISSAUGA, Ontario, Nov. 09, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its...
Updated data from Phase 1 PYNNACLE clinical trial of PC14586 presented at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and...
- Launch of Ghryvelin™ in a number of key countries in the European Economic Area - Approval of Macrilen® in...
Results land amidst surge in drug-resistant organisms and fungal outbreaks, showcase widespread concerns about infection risks in hospitalsBrooklyn, N.Y., Nov....
Patent Covers Novel Optimization of Care by Remote Monitoring Devices Including Smartwatches Oak Ridge, TN, Nov. 09, 2023 (GLOBE NEWSWIRE)...
STOUGHTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed...
CHARLOTTE, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will host...
-- Blocking of α5β1 integrin has been shown to improve motor function and increase survival in the SOD1G93A mouse model of...
Jupiter, Florida--(Newsfile Corp. - November 9, 2023) - My Crew Doses Inc., (the "Company" or "MCD"), an American PhD-led brand...
STOCKHOLM, SWEDEN / ACCESSWIRE / November 9, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced...
NOT INTENDED FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG-KONG, JAPAN, CANADA, SWITZERLAND,...
SAO PAULO / ACCESSWIRE / November 9, 2023 / The Global Self-Care Federation (GSCF) and the United for Self-Care Coalition...
Revenue recognised for 2023 expected to be up 120% at c. £2.2 million with sales secured in 2023 expected to...
ANGLE LAUNCHES PD-L1 TEST TO SUPPORT CANCER THERAPY STUDIESANGLE's Portrait PD-L1 test uses CTCs harvested from the Parsortix system to...
Key Senior Members of Former Amryt Pharma Leadership Team join Poolbeg PharmaPoolbeg team boosted by highly experienced executives with track...
PISCATAWAY, NJ / ACCESSWIRE / November 9, 2023 / Sensors in smartphones and smart speakers could help determine a person's...
JACKSONVILLE, FL / ACCESSWIRE / November 8, 2023 / LFTD Partners Inc. ("LFTD Partners" or the "Company") (OTCQB:LIFD), the corporate...